Skip to content

TheEffect of pH on Misoprostol in Induction of Labor

TheEffect of pH on Misoprostol in Induction of Labor in Full Term Pregnancies

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03829592
Enrollment
180
Registered
2019-02-04
Start date
2019-02-06
Completion date
2020-07-12
Last updated
2020-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor Pain

Brief summary

Misoprostol is a synthetic analogue of the naturally occurring prostaglandin E1. It was initially marketed for the treatment of peptic ulcers due to its mucosal protective and anti-secretory properties, but has commonly been used for the induction of abortion and labour .

Detailed description

Although initially having been established for oral use, misoprostol tablets are commonly used as vaginal suppositories for the previously purposes. Water or saline are frequently used in common practice to moisten the tablets prior to their administration, however, according to the pharmacokinetics of the drug, it should liquefy better in an acidic medium

Interventions

DRUGmisoprostol in a neutral media

giving misoprostol in a neutral media

DRUGmisoprostol in an acidic media

giving misoprostol in an acidic media

DRUGmisoprostol in an alkaline media

giving misoprostol in an alkaline media

Sponsors

Kasr El Aini Hospital
CollaboratorOTHER
Aljazeera Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

3 paralle groups

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 42 Years
Healthy volunteers
Yes

Inclusion criteria

* Singleton pregnancies. Gestational age 38-41 weeks. Cephalic presentation

Exclusion criteria

* 1\. Multi-fetal pregnancy. 2. Pregnant women less than 38 weeks gestation.

Design outcomes

Primary

MeasureTime frameDescription
The number of women who will start lactive phase of labour after treatmentwithin 24 hoursthe number of women in a group who will enter in active labour faster than other groups

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026